Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia - Slideshow (NASDAQ:DSGN) 2026-05-19

2026-05-19. The following slide deck was published by Design Therapeutics, Inc.